genomics

Researchers are spotlighting nutrigenomics, the study of how genes shape individual responses to food, and its role in precision nutrition, which tailors dietary advice to a person's genetic makeup. The field promises personalised diets that could improve health outcomes, though scientists note that large-scale evidence and practical applications are still developing.

10x Genomics is in focus after unveiling a new spatial biology offering and announcing a collaboration with Fred Hutchinson Cancer Center. The moves give the genomics company fresh momentum in a competitive single-cell and spatial analysis market, and investors are watching whether the products and partnership can translate into revenue growth. Market commentators are weighing the announcements against ongoing concerns about the company's financial performance.

A systematic review published in Nature examines how precision medicine may widen or reflect existing health inequalities. The review consolidates evidence on unequal access to genetic testing, targeted therapies and genomic research participation, with disadvantaged groups underrepresented. Researchers and health policy commentators are citing it in ongoing debates about equity in genomics-driven healthcare and who benefits from personalised treatment advances.

ElevateBio is drawing attention with a detailed look at the technologies it uses to engineer precision genetic medicines. The company, which builds cell and gene therapies and supplies the underlying tech to partners, is showcasing its suite of tools for editing and manufacturing genomic medicines. Industry observers see it as part of the broader push to make genetic medicine production more reliable and scalable.

A new science news release highlights Mendelian randomization, a statistical method that uses genetic variants as natural experiments to infer whether biological risk factors truly cause disease, as it gains new power in the era of large genomic and biobank datasets. Researchers are increasingly applying the approach to distinguish genuine causal links from mere correlations in human biology and medicine.

Researchers have published a whole-genome DNA methylation analysis of epithelial ovarian cancer in Nature, reporting that the disease can be separated into subtypes with distinct epigenetic characteristics. The findings could help explain why patients respond differently to treatment and may support more precise classification and targeted therapy in ovarian cancer.

Scientists are using the genomes of Antarctic animals to reconstruct the past behaviour of the East Antarctic Ice Sheet. Because direct geological records are limited, genetic signatures in species that survived past climate shifts can reveal when and where ice retreated and advanced. The research, published in Nature, offers a new way to estimate how the ice sheet responded to earlier warming periods, informing predictions about its future contribution to sea-level rise.

The Earth BioGenome Project has published quality standards and recommendations for generating eukaryotic reference genome assemblies. The guidelines are intended to ensure consistency and accuracy across the thousands of species genomes the initiative aims to sequence. Researchers in genomics and biodiversity science are expected to follow these benchmarks as genome assembly efforts expand worldwide.

Baylor Genetics has been named the lead sequencing partner for a Florida newborn screening pilot, according to an announcement covered by Clinical Lab Products. The program is expected to use genomic sequencing to expand how newborns are screened for genetic conditions in the state. Further details about the pilot's scope, partners, and timeline were not included in the announcement.

Scientists report that DNA sequence from a human brain gene has been found within a virus, a striking example of genetic material crossing between human hosts and viruses. Such findings shed light on how viruses and human genomes exchange genes over evolutionary time, and researchers are now examining what the incorporated sequence might do and how it got there.

Nature has published a piece on neuropsychiatry genetics in Africa, highlighting the state of genetic research into mental and neurological disorders across the continent. The discussion centres on why African populations remain underrepresented in genomic studies of conditions like schizophrenia, depression and epilepsy, and what is needed to build local research capacity, data resources and infrastructure so genetic discoveries can benefit African patients.

Researchers have identified a human brain gene capable of moving, or 'jumping', to new positions within the genome. The finding, reported via ScienceDaily, sheds light on mobile genetic elements and their potential role in brain development and genetic variation. Little further detail beyond the headline has circulated so far, but the discovery is drawing attention for what it could mean for neuroscience and genetics research.

An opinion piece argues that artificial intelligence in biology can only be as reliable as the datasets it is trained on. The author warns that biased, incomplete or low-quality data can undermine AI's promise in biological research, from drug discovery to genomics. The article calls for better data standards and careful validation before AI-driven conclusions are treated as trustworthy science.

Agri-biotech company Soilytix has announced the launch of AI models designed to identify new crop-protection candidates by analysing soil DNA. The company says the approach uses genomic data from soil microbiomes to speed up the discovery of molecules that could protect crops from pests and disease. Details on partnerships, funding or commercial timelines were not included in the initial announcement.

Researchers at the Wellcome Sanger Institute are applying mathematical models to study how cells communicate with one another. The approach aims to make sense of complex signalling data from biological experiments, helping scientists identify which cell interactions matter in healthy tissue and disease. It reflects a growing trend of combining computational methods with genomics research.

Researchers have introduced a new algorithm that models cell fate decisions as binary trees, offering a fresh approach to single-cell trajectory inference. The method aims to better map how stem or progenitor cells branch into distinct fates, a central challenge in developmental biology and disease research. Coverage so far is limited, but the computational biology community is expected to scrutinize how the binary-tree structure compares with existing trajectory tools.

A new landmark review has been published mapping the tools cells use to repair broken DNA. The review brings together current knowledge on DNA repair mechanisms, a field central to understanding cancer, ageing and genetic disease. Researchers say such consolidated overviews help guide future work in genome editing and medicine. Reaction so far appears largely within the scientific community, with broader discussion still limited.

Researchers have used precision IVF techniques to observe the moment mouse embryos activate their own genome, a key early step in development. The work shows how fertilised eggs transition from relying on maternal material to running on their own genes. Scientists say the findings could sharpen understanding of early embryonic development and improve assisted reproduction methods.

A new artificial intelligence approach can phase genomes — determining which genetic variants are inherited from each parent — without relying on a reference panel of previously phased genomes. Reported by Bioengineer.org, the method could make genomic analysis more accessible in populations that are underrepresented in existing genetic databases, though details of the study and its validation have not yet been widely discussed.

A scientific article titled 'Inheritance and selection of the mitochondrial genome' has been published, addressing how mitochondrial DNA is passed from parent to offspring and how certain variants are favoured or eliminated during transmission. Mitochondrial inheritance matters because mutations in this genome cause a range of serious human diseases, and understanding selection mechanisms informs research on genetics, fertility and potential therapies.